Search for: "Dennis Mayo" Results 81 - 100 of 183
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2018, 2:04 am by Dennis Crouch
by Dennis Crouch Ex Parte Simons, APPEAL 2016-002684 (Patent Tr. [read post]
15 Feb 2018, 7:01 am by Dennis Crouch
by Dennis Crouch Following upon its February 8 decision in Berkheimer, the Federal Circuit has again sided with the Patentee on eligibility grounds – holding here that the lower court’s judgment on the pleadings failed to consider disputed issues of material fact. [read post]
5 Feb 2018, 7:30 am by Dennis Crouch
By Dennis Crouch Ex parte Gerlitz, APPEAL 2017-002398, 2018 WL 619852 (PTAB Jan. 26, 2018) GlucoVista’s patent application claims a method of determining glucose concentration in a body (i.e., physical matter) by changing the body’s surface temperature and measuring the change in infrared (IR) radiation emitted at the wavelength associated with Glucose IR emissions. [read post]
10 Jan 2018, 11:22 am by Ed. Microjuris.com Puerto Rico
A continuación publicamos el comunicado del Departamento de Justicia: El Departamento de Justicia y su Secretaria Wanda Vázquez Garced informan hoy que se encontró causa para arresto contra Dennis Montalvo Concepción por hechos ocurridos el 1 de mayo mientras se daba una manifestación en la Milla de Oro. [read post]
21 Dec 2017, 6:34 am by Dennis Crouch
Lemley, Erik Oliver, Kent Richardson, James Yoon, & Michael Costa, Patent Purchases and Litigation Outcomes, 2016 Patently-O Patent Law Journal 15 (Lemley.2016.PatentMarket) Bernard Chao and Amy Mapes, An Early Look at Mayo’s Impact on Personalized Medicine, 2016 Patently-O Patent Law Journal 10 (Chao.2016.PersonalizedMedicine) James E. [read post]
7 Dec 2017, 5:27 am by Dennis Crouch
In Mayo, the Supreme Court held the following to be a “law of nature”: If the blood-level of 6-TG exceeds exceed about 400 pmol per 8×108 red blood cells, then the administration of the standard dose of thiopurine is likely to produce toxic side effects, whereas a blood level of about 230 pmol per 8×108 red blood cells indicates that the standard dose should be increased. [read post]
3 Dec 2017, 10:21 pm by Mark Summerfield
  (A hat-tip, by the way, to Dennis Crouch at the Patently-O blog for bringing this new dataset to my attention, and using it to compare rates of anticipation and obviousness rejections over the period covered by the data.)As interested followers of patent-eligibility (you know who you are) will be aware, during this period the Supreme Court has issued four opinions restricting the scope of patentable subject matter: Bilski v Kappos 130 S.Ct. 3218 (2010), relating to ‘pure’… [read post]
13 Sep 2017, 11:29 am by Jason Rantanen
  In other words, to see cases such as Mayo, Myriad, and Alice through fresh eyes, or to explore the evolution of post-Markman claim construction from Markman to Cybor to Phillips to Teva. [read post]
8 Jun 2017, 3:00 am by Ed. Microjuris.com Puerto Rico
En la carta enviada el 19 de mayo, el CPI plantea además que: “la acústica en la sala del tribunal es terrible. [read post]
15 May 2017, 1:25 pm by Ed. Microjuris.com Puerto Rico
La fianza global impuesta contra el estudiante fue de $45,000 y la vista preliminar fue señalada para el 30 de mayo. [read post]
15 Mar 2017, 7:48 am by Dennis Crouch
Dennis Crouch The principle that patent prosecutors are following today is in the headline: Get Technical or Get Denied. [read post]
7 Mar 2017, 3:16 am by Dennis Crouch
Lemley, Erik Oliver, Kent Richardson, James Yoon, & Michael Costa, Patent Purchases and Litigation Outcomes, 2016 Patently-O Patent Law Journal 15 (Lemley.2016.PatentMarket) Bernard Chao and Amy Mapes, An Early Look at Mayo’s Impact on Personalized Medicine, 2016 Patently-O Patent Law Journal 10 (Chao.2016.PersonalizedMedicine) James E. [read post]
5 Feb 2017, 6:30 pm by Dennis Crouch
by Dennis Crouch The Intellectual Property Owners Association (IPO) is run primarily by a group of 50 top intellectual property counsel (usually patent-focused) from many of the largest global innovative companies – all deeply involved in the patent system as patent holders and many as accused-infringers as well. [read post]
1 Feb 2017, 3:51 am by Dennis Crouch
The court’s approach is surprising considering the current high levels of uncertainty in the areas of patent law procedure (AIA Trials before the PTAB) and doctrine (eligibility under Alice and Mayo) that are being decided without opinion. [read post]